Table 1.
Characteristic | Group 1 (n =15) | Group 2 (n = 15) | Group 3 (n = 20) |
---|---|---|---|
Sex | |||
Male | 11 (73.33%) | 9 (60.00%) | 12 (60.00%) |
Female | 4 (26.67%) | 6 (40.00%) | 8 (40.00%) |
Age (years) | |||
<60 | 10 (66.67%) | 11 (73.33%) | 14 (70.00%) |
≥60 | 5 (33.33%) | 4 (26.67%) | 6 (30.00%) |
T stage | |||
T1 | 5 (33.33%) | 0 (0%) | 0 (0%) |
T2 | 8 (53.33%) | 4 (26.67%) | 5 (25.00%) |
T3 | 2 (13.34%) | 7 (46.66%) | 10 (50.00%) |
T4 | 0 (0%) | 4 (26.67%) | 5 (25.00%) |
N stage | |||
N0 | 0 (0%) | 1 (6.67%) | 0 (0%) |
N1 | 5 (33.33%) | 6 (40.00%) | 1 (5.00%) |
N2 | 10 (66.67%) | 8 (53.33%) | 14 (70.00%) |
N3 | 0 (0%) | 0 (0%) | 5 (25.00%) |
Clinical stage | |||
I | 0 (0%) | 0 (0%) | 0 (0%) |
II | 4 (26.67%) | 2 (13.33%) | 0 (0%) |
III | 11 (73.33%) | 9 (60.00%) | 10 (50.00%) |
IVa | 0 (0%) | 4 (26.67%) | 5 (25.00%) |
IVb | 0 (0%) | 0 (0%) | 5 (25.00%) |